Percentage area reduction at week 4 as a prognostic indicator of complete healing in patients treated with standard of care: a post hoc analysis

被引:0
|
作者
Serena, Thomas [1 ]
Yaakov, Sadia [2 ]
Yaakov, Raphael [3 ]
King, Emily [1 ]
Driver, Vickie R. [4 ,5 ]
机构
[1] SerenaGroup Res Fdn, Cambridge, MA 02140 USA
[2] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
[3] eKare Inc, Fairfax, VA USA
[4] Washington State Univ, Sch Med, Pullman, WA USA
[5] Wound Care Collaborat Community, Dallas, TX USA
关键词
chronic ulcers; clinical decision support; diabetic foot ulcers; percentage area reduction; surrogate endpoints; surrogate marker; topical oxygen therapy; wound; wound care; wound dressing; wound healing; DIABETIC FOOT ULCERS; TOPICAL OXYGEN-THERAPY;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Early indicators of healing provide valuable information on the potential benefit of treatment. In patients with hard-to-heal (chronic) diabetic foot ulcers (DFUs), timely intervention is critical. Ulcers that fail to show measurable progress within four weeks of treatment are considered recalcitrant. These ulcers increase the risk of soft tissue infection, osteomyelitis and lower extremity amputation. A prognostic indicator or surrogate marker allows for rapid evaluation of treatment efficacy and safety. An inverse correlation between a percentage area reduction (PAR) of <= 50% at week 4 and complete healing by week 12 has been previously established; however, the data were derived from a standard of care (SoC) arm of clinical trials that are over a decade old. In this post hoc analysis, data from a large multicentre prospective randomised controlled trial were reviewed to assess PAR at week 4 as a prognostic indicator in patients treated with SoC. Overall, 65.4% (17/26) of patients with PAR >50% at week 4 achieved complete closure at week 12. The receiver operating characteristic (ROC) curve for area reduction by week 4 showed strong discrimination for predicting non-healing (area under the ROC curve: 0.92; p<0.001; positive predictive value: 70.6%; negative predictive value: 87.2%). These findings are consistent with previous studies and support the use of four-week PAR as a prognostic indicator.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Percentage area reduction at week 4 as a prognostic indicator of complete healing in patients treated with standard of care: a post hoc analysis
    Serena, Thomas
    Yaakov, Sadia
    Yaakov, Raphael
    King, Emily
    Driver, Vickie R.
    JOURNAL OF WOUND CARE, 2024, 33 : S36 - S42
  • [2] Analysis of Patients with Glioblastoma Treated with Standard 6-Week Chemoradiation Followed by Temozolomide: Treatment Outcomes and Prognostic Factors
    Lee, Sojung
    Kim, Myungsoo
    MEDICINA-LITHUANIA, 2025, 61 (03):
  • [3] A Post-hoc Analysis of Reduction in Diabetic Foot Ulcer Size at 4 Weeks as a Predictor of Healing by 12 Weeks
    Snyder, Robert J.
    Cardinal, Matthew
    Dauphinee, Damien M.
    Stavosky, James
    OSTOMY WOUND MANAGEMENT, 2010, 56 (03) : 44 - +
  • [4] Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies
    Lipton, Richard B.
    Dodick, David W.
    Kudrow, David
    Reuter, Uwe
    Tenenbaum, Nadia
    Zhang, Feng
    Lima, Gabriel Paiva da Silva
    Chou, Denise E.
    Mikol, Daniel D.
    CEPHALALGIA, 2021, 41 (14) : 1458 - 1466
  • [5] Partial response or better at 6 months is not shown to be a prognostic indicator of progression-free survival in Waldenstrom macroglobulinemia treated with acalabrutinib: a post hoc analysis
    Castillo, Jorge
    Sarosiek, Shayna
    Branagan, Andrew
    von Keudell, Gottfried
    Shaw, Bob
    Treon, Steven
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S274 - S275
  • [6] Fifty percent area reduction after 4 weeks of treatment is a reliable indicator for healing-analysis of a single-center cohort of 704 diabetic patients
    Coerper, Stephan
    Beckert, Stefan
    Kueper, Markus A.
    Jekov, Martin
    Koenigsrainer, Alfted
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (01) : 49 - 53
  • [7] Faecal calprotectin identifies microscopic inflammation in ulcerative colitis patients with complete endoscopic healing: a post-hoc analysis of the MOMENTUM trial
    Stevens, T. W.
    Gecse, K.
    Barrett, K.
    Turner, J. R.
    de Hertogh, G.
    Rubin, D. T.
    D'Haens, G. R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S169 - S169
  • [8] A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI
    Ian Chau
    Florence Joulain
    Sheikh Usman Iqbal
    John Bridgewater
    BMC Cancer, 14
  • [9] A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI
    Chau, Ian
    Joulain, Florence
    Iqbal, Sheikh Usman
    Bridgewater, John
    BMC CANCER, 2014, 14
  • [10] Partial response or better at 6 months is not a prognostic indicator of progression-free survival in Waldenstrom macroglobulinemia treated with zanubrutinib: a post hoc analysis of the ASPEN study
    Castillo, Jorge
    Tedeschi, Alessandra
    Tam, Constantine
    Buske, Christian
    Owen, Roger
    Leblond, Veronique
    Opat, Stephen
    Branagan, Andrew
    Sarosiek, Shayna
    von Keudell, Gottfried
    Treon, Steven
    Allewelt, Heather
    Chan, Wai
    Schneider, Jingjing
    Dimopoulos, Meletios
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S274 - S274